Which of the following antihypertensive drugs is contraindicated in pregnancy:
**Core Concept**
The question is testing the knowledge of antihypertensive drug safety in pregnancy. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are known to be teratogenic and contraindicated in pregnancy due to their potential to cause fetal renal damage.
**Why the Correct Answer is Right**
ACEIs and ARBs inhibit the renin-angiotensin-aldosterone system (RAAS), which plays a crucial role in maintaining blood pressure and electrolyte balance. In fetal development, the RAAS is also active, and inhibition of this system can lead to oligohydramnios, fetal renal damage, and other congenital anomalies. This is because the fetal kidneys are dependent on the RAAS for normal development and function.
**Why Each Wrong Option is Incorrect**
**Option A:** Diuretics are not contraindicated in pregnancy and are often used to manage hypertension in pregnant women. They work by increasing urine production, which can help to lower blood pressure.
**Option B:** Calcium channel blockers (CCBs) are generally considered safe in pregnancy and are often used to manage hypertension in pregnant women. They work by inhibiting the influx of calcium ions into vascular smooth muscle cells, which leads to vasodilation and a decrease in blood pressure.
**Option C:** Hydralazine is a vasodilator that is often used to manage severe hypertension in pregnant women. It works by relaxing smooth muscle cells in blood vessels, which leads to vasodilation and a decrease in blood pressure. However, it is not contraindicated in pregnancy.
**Clinical Pearl / High-Yield Fact**
When managing hypertension in pregnancy, it's essential to avoid ACEIs and ARBs due to their potential teratogenic effects. Instead, diuretics, CCBs, or hydralazine may be used to manage blood pressure.
**Correct Answer: A. ACEIs are contraindicated in pregnancy due to their potential to cause fetal renal damage.**